Bovine Respiratory Disease Treatment Market Size (2024 - 2029)

Bovine Respiratory Disease Treatment Market Analysis

The Bovine Respiratory Disease Treatment Market is poised to grow at a CAGR of 11.5% over the forecast period.

The COVID-19 pandemic disrupted animal health care during the initial stages of the pandemic. The strict lockdown imposition of lockdown affected the accessibility to veterinary clinics, thus impacting the market's growth over the pandemic phase. According to the study published in the Indian Journal of Animal Science in June 2022, there was a significant difference in the number of cases attended across different lockdown periods and among veterinarians, with a decline in the number of cases attended across pet species (54.9%), followed by goats (35.3%), sheep (29.1%), cattle (25.5%), and buffalo (21.6%). During the lockdown, veterinarian visits fell by 27.3%, while farmer visits to veterinary clinics fell by 61.9%, thus impacting the market growth adversely in the initial pandemic phase. However, with the resumption of veterinary services worldwide, the market is likely to gain traction over the forecast period.

The increasing consumption of beef and the rising population are the major factors driving the market studied. According to the article published in TWC in 2022, the global beef consumption stood at 350 million tons a year, and by 2050 the global meat consumption is projected to reach between 460 million. As a result, global beef consumption is increasing, which necessitates greater attention to livestock diseases such as bovine respiratory diseases, thereby contributing to the market's growth over the forecast period.

In addition, Bovine Respiratory Disease (BRD) adversely affects the reproductive performance, growth, and lifespan of cattle. Hence, this necessitates the need for BRD treatment globally. According to the Elsevier article published in 2021, the average cumulative incidence of bovine respiratory disease in high-performing livestock was 12.8% and among the high-risk group of livestock was 15.1%. Thus, the growing prevalence of bovine respiratory diseases among livestock is expected to contribute to the market's growth over the forecast period.

Also, various market players are taking strategic initiatives for the development of new products and strengthening their position in the market. For instance, in August 2021, Zoetis launched a new combination product to treat Bovine Respiratory Disease (BRD) and control related fever (pyrexia): Draxxin KP (tulathromycin and ketoprofen injection) Injectable Solution.

Thus, all the aforementioned factors, such as rising meat consumption, increasing bovine respiratory diseases, and rising product launches, are expected to boost the market's growth. However, the shortage of skilled veterinarians may restrain the market's growth.

Bovine Respiratory Disease Treatment Industry Segmentation

As per the scope of the report, Bovine Respiratory Disease (BRD) is the general term used for respiratory diseases in cattle or bovines. BRD is usually caused by both viral and bacterial pathogens and can affect the lower respiratory tract and upper respiratory tract. 

The Bovine Respiratory Disease Treatment market is segmented by Treatment Type (Vaccines, Antibiotics, NSAIDs, Immunomodulators, and Other Treatment Types), Disease Type (Lower Respiratory Tract Infections, Upper Respiratory Tract Infections, Diphtheria), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.